Recursion Pharmaceuticals, Inc. · Biotechnology
RXRXRecursion Pharmaceuticals, Inc.
No earnings date on file for this stock yet.
Lean, stance and evidence on this page are model outputs, not investment advice. Trade at your own risk. Disclaimer →
Recursion Pharmaceuticals earnings preview: what the record says
Across its last 8 reports, RXRX beat the EPS consensus 3 times out of 8 with a figure on file, and the stock moved an average of 4.7% on the first trading day, closing higher 2 of 8 times. That first-day move was larger than the options-implied move in 1 of 8 reports. Measured over five sessions, the average move was 8.8%.
Historically, RXRX has usually stayed inside its implied move. NextPick tracks RXRX in its AI Drug Discovery basket alongside TEM, ABCL, SDGR and CERT, whose prints read through to this one.
Figures come from NextPick's earnings-reaction ledger and the options market. Not investment advice.
RXRX earnings: key questions
How much does RXRX stock move after earnings?
Over its last 8 reports, RXRX moved an average of 4.7% on the first trading day after earnings. The move was larger than the options-implied move in 1 of 8 reports.
Does RXRX usually beat earnings estimates?
RXRX beat the EPS consensus in 3 of its last 8 reports with a surprise on file and missed in 5.